Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.11% Nasdaq Up0.18%

Regeneron Pharmaceuticals, Inc. (REGN)

-NMS

266.79 Down 0.18(0.07%) 11:22AM EDT - Nasdaq Real Time Price

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Net Income 750,269   (221,760) (104,468)
Operating Activities, Cash Flows Provided By or Used In
Depreciation36,940  31,082  19,687  
Adjustments To Net Income(189,025)67,419  43,977  
Changes In Accounts Receivables(590,085)(21,118)(17,518)
Changes In Liabilities(30,098)9,687  165,756  
Changes In Inventories -   -   -  
Changes In Other Operating Activities(52,616)(6,992)(8,212)
Total Cash Flow From Operating Activities (74,615) (141,682) 99,222  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(49,337)(57,217)(99,689)
Investments(31,184)185,965  (331,401)
Other Cash flows from Investing Activities(552)(277)(5,941)
Total Cash Flows From Investing Activities (81,073) 128,471   (437,031)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock63,549  137,387  200,588  
Net Borrowings(2,203)389,440  46,516  
Other Cash Flows from Financing Activities(163,300)(25,078)(3,798)
Total Cash Flows From Financing Activities (97,646) 384,249   243,306  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents (253,334) 371,038   (94,503)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.